MedPath

Trans Nasal Insufflation for the Treatment of Snoring

Completed
Conditions
Obstructive Sleep Apnea
Interventions
Device: Trans Nasal Insufflation (TNI) [nasal canula]
Registration Number
NCT00832026
Lead Sponsor
Johns Hopkins University
Brief Summary

This research is being done to examine if a nasal cannula can be used to keep the throat open during sleep, thereby treating sleep apnea.

People with sleep apnea and people who snore without sleep apnea may take part in this study. Sleep apnea is a disorder caused by pauses in breathing due to repetitive closure of the throat. The most common form of treatment for sleep apnea is continuous positive airway pressure (CPAP) therapy. While CPAP therapy remains the simplest and most effective treatment for snoring and sleep apnea, patients have to wear a nasal mask throughout the night. For this reason, patients often have difficulty sticking to therapy.

Participants enrolled in this study will spend 3-nights in a sleep laboratory. In all nights, the investigators will monitor your sleep and your breathing throughout the night. The investigators will apply several electrodes (sensors) to your scalp and face to monitor your sleep and breathing, and other sensors to your chest, abdomen, cheek, and a finger to monitor your breathing and oxygen level.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
11
Inclusion Criteria
  • Consenting adults over the age of 21
  • Diagnosed obstructive sleep apnea
Read More
Exclusion Criteria
  • Unstable cardiovascular disease
  • Uncontrolled hypertension (BP > 190/110)
  • Severe intrinsic lung diseases (supplemental O2 > 2 L/min during the day)
  • History of chronic renal insufficiency
  • History of hepatic insufficiency
  • Pregnancy
  • Bleeding disorders or Coumadin use
  • Sleep Disorders other than Obstructive Sleep Apnea (OSA)
  • Tracheostomy
  • Allergy to lidocaine
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Sleep apneaTrans Nasal Insufflation (TNI) [nasal canula]Patients with diagnosed obstructive sleep apnea
Primary Outcome Measures
NameTimeMethod
Change in inspiratory airflow2 nights
Secondary Outcome Measures
NameTimeMethod
Change in sleep apnea severity (AHI)2 nights
Change in Ratio of apnea-to-hypopnea events2-nights

Trial Locations

Locations (1)

Johns Hopkins University

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath